Journal Article
. 2014 Oct; 111(41):14846-51.
doi: 10.1073/pnas.1407447111.

Disruption of the immune-checkpoint VISTA gene imparts a proinflammatory phenotype with predisposition to the development of autoimmunity

Li Wang 1 Isabelle Le Mercier 2 Juan Putra 3 Wenna Chen 4 Jun Liu 4 Austin D Schenk 5 Elizabeth C Nowak 2 Arief A Suriawinata 3 Jiannan Li 2 Randolph J Noelle 6 
  • PMID: 25267631
  •     30 References
  •     70 citations


V domain-containing Ig suppressor of T-cell activation (VISTA) is a negative checkpoint regulator that suppresses T cell-mediated immune responses. Previous studies using a VISTA-neutralizing monoclonal antibody show that VISTA blockade enhances T-cell activation. The current study describes a comprehensive characterization of mice in which the gene for VISTA has been deleted. Despite the apparent normal hematopoietic development in young mice, VISTA genetic deficiency leads to a gradual accumulation of spontaneously activated T cells, accompanied by the production of a spectrum of inflammatory cytokines and chemokines. Enhanced T-cell responsiveness was also observed upon immunization with neoantigen. Despite the presence of multiorgan chronic inflammation, aged VISTA-deficient mice did not develop systemic or organ-specific autoimmune disease. Interbreeding of the VISTA-deficient mice with 2D2 T-cell receptor transgenic mice, which are predisposed to the development of experimental autoimmune encephalomyelitis, drastically enhanced disease incidence and intensity. Disease development is correlated with the increase in the activation of encephalitogenic T cells in the periphery and enhanced infiltration into the CNS. Taken together, our data suggest that VISTA is a negative checkpoint regulator whose loss of function lowers the threshold for T-cell activation, allowing for an enhanced proinflammatory phenotype and an increase in the frequency and intensity of autoimmunity under susceptible conditions.

Keywords: autoimmunity; immune suppression; inflammation; peripheral tolerance.

Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice.
H Nishimura, T Okazaki, +8 authors, T Honjo.
Science, 2001 Feb 24; 291(5502). PMID: 11209085
Highly Cited.
Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4.
E A Tivol, F Borriello, +3 authors, A H Sharpe.
Immunity, 1995 Nov 01; 3(5). PMID: 7584144
Highly Cited.
Tissue expression of PD-L1 mediates peripheral T cell tolerance.
Mary E Keir, Spencer C Liang, +7 authors, Arlene H Sharpe.
J Exp Med, 2006 Apr 12; 203(4). PMID: 16606670    Free PMC article.
Highly Cited.
Control of peripheral T-cell tolerance and autoimmunity via the CTLA-4 and PD-1 pathways.
Brian T Fife, Jeffrey A Bluestone.
Immunol Rev, 2008 Sep 02; 224. PMID: 18759926
Highly Cited. Review.
Activating Fc γ receptors contribute to the antitumor activities of immunoregulatory receptor-targeting antibodies.
Yannick Bulliard, Rose Jolicoeur, +6 authors, Jennifer L Brogdon.
J Exp Med, 2013 Jul 31; 210(9). PMID: 23897982    Free PMC article.
Highly Cited.
The B7 family revisited.
Rebecca J Greenwald, Gordon J Freeman, Arlene H Sharpe.
Annu Rev Immunol, 2005 Mar 18; 23. PMID: 15771580
Highly Cited. Review.
Differential role of programmed death-ligand 1 [corrected] and programmed death-ligand 2 [corrected] in regulating the susceptibility and chronic progression of experimental autoimmune encephalomyelitis.
Bing Zhu, Indira Guleria, +6 authors, Samia J Khoury.
J Immunol, 2006 Mar 07; 176(6). PMID: 16517716
The programmed death-1 (PD-1) pathway regulates autoimmune diabetes in nonobese diabetic (NOD) mice.
Mohammed Javeed I Ansari, Alan D Salama, +9 authors, Mohamed H Sayegh.
J Exp Med, 2003 Jul 09; 198(1). PMID: 12847137    Free PMC article.
Highly Cited.
Programmed death 1 ligand (PD-L) 1 and PD-L2 limit autoimmune kidney disease: distinct roles.
Julia Menke, Julie A Lucas, +7 authors, Vicki R Kelley.
J Immunol, 2007 Nov 21; 179(11). PMID: 18025191
Myelin oligodendrocyte glycoprotein-specific T cell receptor transgenic mice develop spontaneous autoimmune optic neuritis.
Estelle Bettelli, Maria Pagany, +3 authors, Vijay K Kuchroo.
J Exp Med, 2003 May 07; 197(9). PMID: 12732654    Free PMC article.
Highly Cited.
VISTA Regulates the Development of Protective Antitumor Immunity.
Isabelle Le Mercier, Wenna Chen, +5 authors, Li Wang.
Cancer Res, 2014 Apr 03; 74(7). PMID: 24691994    Free PMC article.
Highly Cited.
A modified tyrosinase-related protein 2 epitope generates high-affinity tumor-specific T cells but does not mediate therapeutic efficacy in an intradermal tumor model.
Jennifer A McWilliams, Sean M McGurran, +2 authors, Ross M Kedl.
J Immunol, 2006 Jun 21; 177(1). PMID: 16785510
Fine tuning the immune response through B7-H3 and B7-H4.
Kyung H Yi, Lieping Chen.
Immunol Rev, 2009 May 12; 229(1). PMID: 19426220    Free PMC article.
Programmed death 1 ligand signaling regulates the generation of adaptive Foxp3+CD4+ regulatory T cells.
Li Wang, Karina Pino-Lagos, +3 authors, Randolph J Noelle.
Proc Natl Acad Sci U S A, 2008 Jul 05; 105(27). PMID: 18599457    Free PMC article.
Highly Cited.
Naive CD4(+) T cell frequency varies for different epitopes and predicts repertoire diversity and response magnitude.
James J Moon, H Hamlet Chu, +4 authors, Marc K Jenkins.
Immunity, 2007 Aug 21; 27(2). PMID: 17707129    Free PMC article.
Highly Cited.
Combination immunotherapy of B16 melanoma using anti-cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) and granulocyte/macrophage colony-stimulating factor (GM-CSF)-producing vaccines induces rejection of subcutaneous and metastatic tumors accompanied by autoimmune depigmentation.
A van Elsas, A A Hurwitz, J P Allison.
J Exp Med, 1999 Aug 03; 190(3). PMID: 10430624    Free PMC article.
Highly Cited.
Critical role of the programmed death-1 (PD-1) pathway in regulation of experimental autoimmune encephalomyelitis.
Alan D Salama, Tanuja Chitnis, +7 authors, Samia J Khoury.
J Exp Med, 2003 Jul 09; 198(1). PMID: 12847138    Free PMC article.
Highly Cited.
Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor.
H Nishimura, M Nose, +2 authors, T Honjo.
Immunity, 1999 Sep 15; 11(2). PMID: 10485649
Highly Cited.
Interferon γ limits the effectiveness of melanoma peptide vaccines.
Hyun-Il Cho, Young-Ran Lee, Esteban Celis.
Blood, 2010 Oct 05; 117(1). PMID: 20889921    Free PMC article.
VISTA is an immune checkpoint molecule for human T cells.
J Louise Lines, Eirini Pantazi, +8 authors, Randolph Noelle.
Cancer Res, 2014 Apr 03; 74(7). PMID: 24691993    Free PMC article.
Highly Cited.
Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4.
P Waterhouse, J M Penninger, +6 authors, T W Mak.
Science, 1995 Nov 10; 270(5238). PMID: 7481803
Highly Cited.
VISTA, a novel mouse Ig superfamily ligand that negatively regulates T cell responses.
Li Wang, Rotem Rubinstein, +10 authors, Randolph J Noelle.
J Exp Med, 2011 Mar 09; 208(3). PMID: 21383057    Free PMC article.
Highly Cited.
Enhanced efficacy and reduced toxicity of multifactorial adjuvants compared with unitary adjuvants as cancer vaccines.
Cory L Ahonen, Anna Wasiuk, +7 authors, Randolph J Noelle.
Blood, 2008 Jan 19; 111(6). PMID: 18202224    Free PMC article.
Tumor-specific Th17-polarized cells eradicate large established melanoma.
Pawel Muranski, Andrea Boni, +14 authors, Nicholas P Restifo.
Blood, 2008 Mar 21; 112(2). PMID: 18354038    Free PMC article.
Highly Cited.
A mouse knockout library for secreted and transmembrane proteins.
Tracy Tang, Li Li, +20 authors, Frederic J de Sauvage.
Nat Biotechnol, 2010 Jun 22; 28(7). PMID: 20562862
Highly Cited.
Cutting Edge: Programmed death (PD) ligand-1/PD-1 interaction is required for CD8+ T cell tolerance to tissue antigens.
Natalia Martin-Orozco, Yi-Hong Wang, Hideo Yagita, Chen Dong.
J Immunol, 2006 Dec 05; 177(12). PMID: 17142723
Coinhibitory receptor PD-1H preferentially suppresses CD4⁺ T cell-mediated immunity.
Dallas B Flies, Xue Han, +4 authors, Lieping Chen.
J Clin Invest, 2014 Apr 20; 124(5). PMID: 24743150    Free PMC article.
Highly Cited.
Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti-CTLA-4 therapy against melanoma.
Tyler R Simpson, Fubin Li, +11 authors, Sergio A Quezada.
J Exp Med, 2013 Jul 31; 210(9). PMID: 23897981    Free PMC article.
Highly Cited.
Combined TLR and CD40 triggering induces potent CD8+ T cell expansion with variable dependence on type I IFN.
Cory L Ahonen, Christie L Doxsee, +6 authors, Ross M Kedl.
J Exp Med, 2004 Mar 10; 199(6). PMID: 15007094    Free PMC article.
Highly Cited.
B7-H1 determines accumulation and deletion of intrahepatic CD8(+) T lymphocytes.
Haidong Dong, Gefeng Zhu, +3 authors, Lieping Chen.
Immunity, 2004 Mar 20; 20(3). PMID: 15030776
Highly Cited.
Immune-checkpoint proteins VISTA and PD-1 nonredundantly regulate murine T-cell responses.
Jun Liu, Ying Yuan, +8 authors, Li Wang.
Proc Natl Acad Sci U S A, 2015 May 13; 112(21). PMID: 25964334    Free PMC article.
Highly Cited.
Control of signaling-mediated clearance of apoptotic cells by the tumor suppressor p53.
Kyoung Wan Yoon, Sanguine Byun, +13 authors, Sam W Lee.
Science, 2015 Aug 01; 349(6247). PMID: 26228159    Free PMC article.
Highly Cited.
Beyond CTLA-4 and PD-1, the Generation Z of Negative Checkpoint Regulators.
Isabelle Le Mercier, J Louise Lines, Randolph J Noelle.
Front Immunol, 2015 Sep 09; 6. PMID: 26347741    Free PMC article.
Highly Cited. Review.
Novel Immune Check-Point Regulators in Tolerance Maintenance.
Yanxia Guo, Adele Y Wang.
Front Immunol, 2015 Sep 09; 6. PMID: 26347744    Free PMC article.
Immune checkpoint inhibitors: therapeutic advances in melanoma.
Ivan Márquez-Rodas, Pablo Cerezuela, +4 authors, Salvador Martín-Algarra.
Ann Transl Med, 2015 Nov 26; 3(18). PMID: 26605313    Free PMC article.
Coinhibitory Pathways in the B7-CD28 Ligand-Receptor Family.
Frank A Schildberg, Sarah R Klein, Gordon J Freeman, Arlene H Sharpe.
Immunity, 2016 May 19; 44(5). PMID: 27192563    Free PMC article.
Highly Cited. Review.
Large-Scale Exome-wide Association Analysis Identifies Loci for White Blood Cell Traits and Pleiotropy with Immune-Mediated Diseases.
Salman M Tajuddin, Ursula M Schick, +94 authors, Paul L Auer.
Am J Hum Genet, 2016 Jun 28; 99(1). PMID: 27346689    Free PMC article.
Immune checkpoints and rheumatic diseases: what can cancer immunotherapy teach us?
Michiel van der Vlist, Jurgen Kuball, Timothy R D Radstake, Linde Meyaard.
Nat Rev Rheumatol, 2016 Aug 20; 12(10). PMID: 27539666
Dies1/VISTA expression loss is a recurrent event in gastric cancer due to epigenetic regulation.
Patrícia Oliveira, Joana Carvalho, +9 authors, Carla Oliveira.
Sci Rep, 2016 Oct 11; 6. PMID: 27721458    Free PMC article.
VISTA Deficiency Accelerates the Development of Fatal Murine Lupus Nephritis.
Sabrina Ceeraz, Petra A Sergent, +4 authors, Randolph J Noelle.
Arthritis Rheumatol, 2016 Dec 20; 69(4). PMID: 27992697    Free PMC article.
T cell exhaustion: from pathophysiological basics to tumor immunotherapy.
Kemal Catakovic, Eckhard Klieser, Daniel Neureiter, Roland Geisberger.
Cell Commun Signal, 2017 Jan 12; 15(1). PMID: 28073373    Free PMC article.
Highly Cited. Review.
Immunoregulatory functions of VISTA.
Elizabeth C Nowak, J Louise Lines, +7 authors, Randolph J Noelle.
Immunol Rev, 2017 Mar 05; 276(1). PMID: 28258694    Free PMC article.
Highly Cited. Review.
Immune-checkpoint protein VISTA critically regulates the IL-23/IL-17 inflammatory axis.
Na Li, Wenwen Xu, +11 authors, Li Wang.
Sci Rep, 2017 May 05; 7(1). PMID: 28469254    Free PMC article.
A crucial role of the PD-1H coinhibitory receptor in suppressing experimental asthma.
Huafeng Liu, Xin Li, +4 authors, Lieping Chen.
Cell Mol Immunol, 2017 May 10; 15(9). PMID: 28479600    Free PMC article.
Blocking the VISTA pathway enhances disease progression in (NZB × NZW) F1 female mice.
P A Sergent, S F Plummer, +6 authors, S Ceeraz.
Lupus, 2017 Jul 01; 27(2). PMID: 28659048    Free PMC article.
Programmed death one homolog maintains the pool size of regulatory T cells by promoting their differentiation and stability.
Qi Wang, Jianwei He, +2 authors, Lieping Chen.
Sci Rep, 2017 Jul 22; 7(1). PMID: 28729608    Free PMC article.
VISTA.COMP - an engineered checkpoint receptor agonist that potently suppresses T cell-mediated immune responses.
Aaron Prodeus, Aws Abdul-Wahid, +9 authors, Jean Gariépy.
JCI Insight, 2017 Sep 22; 2(18). PMID: 28931757    Free PMC article.
Checkpoint Inhibitors: Applications for Autoimmunity.
Anna S Tocheva, Adam Mor.
Curr Allergy Asthma Rep, 2017 Sep 29; 17(10). PMID: 28956259    Free PMC article.
VISTA deficiency attenuates antibody-induced arthritis and alters macrophage gene expression in response to simulated immune complexes.
Sabrina Ceeraz, Susan K Eszterhas, +9 authors, Roy A Fava.
Arthritis Res Ther, 2017 Dec 09; 19(1). PMID: 29216931    Free PMC article.
The structure, expression, and multifaceted role of immune-checkpoint protein VISTA as a critical regulator of anti-tumor immunity, autoimmunity, and inflammation.
Wenwen Xu, TạMinh Hiếu, Subramaniam Malarkannan, Li Wang.
Cell Mol Immunol, 2018 Jan 30; 15(5). PMID: 29375120    Free PMC article.
Gene array analysis of PD-1H overexpressing monocytes reveals a pro-inflammatory profile.
Preeti Bharaj, Chunting Ye, +5 authors, Guohua Yi.
Heliyon, 2018 Mar 13; 4(2). PMID: 29527580    Free PMC article.
VISTA expression associated with CD8 confers a favorable immune microenvironment and better overall survival in hepatocellular carcinoma.
Ming Zhang, Hua-Jin Pang, +4 authors, Xiao-Feng He.
BMC Cancer, 2018 May 04; 18(1). PMID: 29720116    Free PMC article.
Emerging strategies for combination checkpoint modulators in cancer immunotherapy.
Aleksandra Popovic, Elizabeth M Jaffee, Neeha Zaidi.
J Clin Invest, 2018 Aug 02; 128(8). PMID: 30067248    Free PMC article.
Highly Cited. Review.
Immuno-Oncology: Emerging Targets and Combination Therapies.
Henry T Marshall, Mustafa B A Djamgoz.
Front Oncol, 2018 Sep 08; 8. PMID: 30191140    Free PMC article.
Highly Cited. Review.
Not All Immune Checkpoints Are Created Equal.
Annika De Sousa Linhares, Judith Leitner, Katharina Grabmeier-Pfistershammer, Peter Steinberger.
Front Immunol, 2018 Sep 21; 9. PMID: 30233564    Free PMC article.
Highly Cited. Review.
The Role of Immune Checkpoint Receptors in Regulating Immune Reactivity in Lupus.
Kun-Lin Lu, Ming-Ying Wu, +4 authors, Chun-Bing Chen.
Cells, 2019 Oct 11; 8(10). PMID: 31597242    Free PMC article.
Defining the Signature of VISTA on Myeloid Cell Chemokine Responsiveness.
Thomas W K Broughton, Mohamed A ElTanbouly, +10 authors, J Louise Lines.
Front Immunol, 2019 Dec 06; 10. PMID: 31803182    Free PMC article.
Structural insight into T cell coinhibition by PD-1H (VISTA).
Benjamin T Slater, Xue Han, Lieping Chen, Yong Xiong.
Proc Natl Acad Sci U S A, 2020 Jan 11; 117(3). PMID: 31919279    Free PMC article.
IgSF11 regulates osteoclast differentiation through association with the scaffold protein PSD-95.
Hyunsoo Kim, Noriko Takegahara, +9 authors, Yongwon Choi.
Bone Res, 2020 Feb 13; 8. PMID: 32047704    Free PMC article.
Immune-Checkpoint Protein VISTA Regulates Antitumor Immunity by Controlling Myeloid Cell-Mediated Inflammation and Immunosuppression.
Wenwen Xu, Juan Dong, +10 authors, Li Wang.
Cancer Immunol Res, 2019 Jul 26; 7(9). PMID: 31340983    Free PMC article.
VISTA expressed in tumour cells regulates T cell function.
Kumuluzi Mulati, Junzo Hamanishi, +14 authors, Masaki Mandai.
Br J Cancer, 2018 Nov 02; 120(1). PMID: 30382166    Free PMC article.
CD71+VISTA+ erythroid cells promote the development and function of regulatory T cells through TGF-β.
Shima Shahbaz, Najmeh Bozorgmehr, +4 authors, Shokrollah Elahi.
PLoS Biol, 2018 Dec 15; 16(12). PMID: 30550561    Free PMC article.
VISTA expression by microglia decreases during inflammation and is differentially regulated in CNS diseases.
Malte Borggrewe, Corien Grit, +5 authors, Jon D Laman.
Glia, 2018 Oct 12; 66(12). PMID: 30306644    Free PMC article.
VISTA: Coming of age as a multi-lineage immune checkpoint.
M A ElTanbouly, E Schaafsma, R J Noelle, J L Lines.
Clin Exp Immunol, 2020 Jan 14; 200(2). PMID: 31930484    Free PMC article.
VISTA: a novel immunotherapy target for normalizing innate and adaptive immunity.
Mohamed A ElTanbouly, Walburga Croteau, Randolph J Noelle, J Louise Lines.
Semin Immunol, 2019 Oct 13; 42. PMID: 31604531    Free PMC article.
P53: A Guardian of Immunity Becomes Its Saboteur through Mutation.
Arjelle Decasa Agupitan, Paul Neeson, +3 authors, Ygal Haupt.
Int J Mol Sci, 2020 May 18; 21(10). PMID: 32414156    Free PMC article.
New emerging targets in cancer immunotherapy: the role of VISTA.
Marco Tagliamento, Paolo Bironzo, Silvia Novello.
ESMO Open, 2020 Jun 20; 4(Suppl 3). PMID: 32554470    Free PMC article.
VISTA is a checkpoint regulator for naïve T cell quiescence and peripheral tolerance.
Mohamed A ElTanbouly, Yanding Zhao, +19 authors, Randolph J Noelle.
Science, 2020 Jan 18; 367(6475). PMID: 31949051    Free PMC article.
Harnessing the Complete Repertoire of Conventional Dendritic Cell Functions for Cancer Immunotherapy.
Lukas Amon, Lukas Hatscher, +2 authors, Christian H K Lehmann.
Pharmaceutics, 2020 Jul 18; 12(7). PMID: 32674488    Free PMC article.
Single-cell RNA-Seq reveals the transcriptional landscape and heterogeneity of skin macrophages in Vsir-/- murine psoriasis.
Chenxin Qie, Jingwei Jiang, +4 authors, Jun Liu.
Theranostics, 2020 Sep 16; 10(23). PMID: 32929361    Free PMC article.
Exploring the VISTA of microglia: immune checkpoints in CNS inflammation.
Malte Borggrewe, Susanne M Kooistra, +2 authors, Jon D Laman.
J Mol Med (Berl), 2020 Aug 29; 98(10). PMID: 32856125    Free PMC article.
VISTA is an acidic pH-selective ligand for PSGL-1.
Robert J Johnston, Linhui Julie Su, +33 authors, Alan J Korman.
Nature, 2019 Oct 28; 574(7779). PMID: 31645726
Running to Stand Still: Naive CD8+ T Cells Actively Maintain a Program of Quiescence.
Taylah J Bennett, Vibha A V Udupa, Stephen J Turner.
Int J Mol Sci, 2020 Dec 30; 21(24). PMID: 33371448    Free PMC article.
Prognostic significance and therapeutic potential of the immune checkpoint VISTA in pancreatic cancer.
Zelin Hou, Yu Pan, +8 authors, Heguang Huang.
J Cancer Res Clin Oncol, 2020 Nov 26; 147(2). PMID: 33237432    Free PMC article.

;. PMID: 33558477
Immunotherapy Targeting Myeloid-Derived Suppressor Cells (MDSCs) in Tumor Microenvironment.
Xidan Gao, Hongshu Sui, +3 authors, Peng Qu.
Front Immunol, 2021 Feb 23; 11. PMID: 33613512    Free PMC article.
VISTA: A Target to Manage the Innate Cytokine Storm.
Mohamed A ElTanbouly, Yanding Zhao, +4 authors, Randolph J Noelle.
Front Immunol, 2021 Mar 02; 11. PMID: 33643285    Free PMC article.
Rethinking peripheral T cell tolerance: checkpoints across a T cell's journey.
Mohamed A ElTanbouly, Randolph J Noelle.
Nat Rev Immunol, 2020 Oct 21; 21(4). PMID: 33077935
The Regulatory Cross-Talk between microRNAs and Novel Members of the B7 Family in Human Diseases: A Scoping Review.
Noora Karim Ahangar, Nima Hemmat, +9 authors, Behzad Baradaran.
Int J Mol Sci, 2021 Apr 04; 22(5). PMID: 33800752    Free PMC article.
Systematic Review.
Structural Basis of VSIG3: The Ligand for VISTA.
Xiaoxue Xie, Caiping Chen, +5 authors, Jun Liu.
Front Immunol, 2021 Apr 13; 12. PMID: 33841409    Free PMC article.
Terminating Cancer by Blocking VISTA as a Novel Immunotherapy: Hasta la vista, baby.
Ji-Eun Irene Yum, Young-Kwon Hong.
Front Oncol, 2021 May 04; 11. PMID: 33937071    Free PMC article.
Immune Checkpoints, a Novel Class of Therapeutic Targets for Autoimmune Diseases.
Yujia Zhai, Reza Moosavi, Mingnan Chen.
Front Immunol, 2021 May 11; 12. PMID: 33968036    Free PMC article.
VISTA regulates microglia homeostasis and myelin phagocytosis, and is associated with MS lesion pathology.
Malte Borggrewe, Susanne M Kooistra, +9 authors, Jon D Laman.
Acta Neuropathol Commun, 2021 May 20; 9(1). PMID: 34006329    Free PMC article.
The Role of V-Domain Ig Suppressor of T Cell Activation (VISTA) in Cancer Therapy: Lessons Learned and the Road Ahead.
Negar Hosseinkhani, Afshin Derakhshani, +7 authors, Behzad Baradaran.
Front Immunol, 2021 Jun 08; 12. PMID: 34093577    Free PMC article.
VISTA is an activating receptor in human monocytes.
Bryan M Rogers, Laura Smith, +14 authors, Gabriel R Starbeck-Miller.
J Exp Med, 2021 Jun 10; 218(8). PMID: 34106206    Free PMC article.
VISTA: A Promising Target for Cancer Immunotherapy?
Marco Tagliamento, Elisa Agostinetto, +4 authors, Matteo Lambertini.
Immunotargets Ther, 2021 Jul 01; 10. PMID: 34189130    Free PMC article.
Detection of Immune Checkpoint Receptors - A Current Challenge in Clinical Flow Cytometry.
Benjamin Shibru, Katharina Fey, +8 authors, Andreas Boldt.
Front Immunol, 2021 Jul 20; 12. PMID: 34276685    Free PMC article.
PD-1 and beyond to Activate T Cells in Cutaneous Squamous Cell Cancers: The Case for 4-1BB and VISTA Antibodies in Combination Therapy.
Quentin Wright, Jazmina L Gonzalez Cruz, James W Wells, Graham R Leggatt.
Cancers (Basel), 2021 Jul 21; 13(13). PMID: 34282763    Free PMC article.
High-Affinity Anti-VISTA Antibody Protects against Sepsis by Inhibition of T Lymphocyte Apoptosis and Suppression of the Inflammatory Response.
Tianzhu Tao, Lulong Bo, +7 authors, Guorong Zhang.
Mediators Inflamm, 2021 Aug 10; 2021. PMID: 34366711    Free PMC article.
Clinical Research on the Mechanisms Underlying Immune Checkpoints and Tumor Metastasis.
Xi-Yang Tang, An-Ping Shi, +5 authors, Jin-Bo Zhao.
Front Oncol, 2021 Aug 10; 11. PMID: 34367975    Free PMC article.
Immune suppressive checkpoint interactions in the tumour microenvironment of primary liver cancers.
Guoying Zhou, Patrick P C Boor, +2 authors, Jaap Kwekkeboom.
Br J Cancer, 2021 Aug 18; 126(1). PMID: 34400801    Free PMC article.
VISTA facilitates phagocytic clearance of HIV infected CEM-SS T cells.
Xuequn Xu, Sean Petersen, Cynthia Rodriguez, Guohua Yi.
Heliyon, 2021 Aug 18; 7(7). PMID: 34401556    Free PMC article.
VISTA Blockade Aggravates Bone Loss in Experimental Murine Apical Periodontitis.
Fuhua Yang, Yifei Zhang, Zhi Chen, Lu Zhang.
Front Immunol, 2021 Oct 26; 12. PMID: 34691045    Free PMC article.
The immune checkpoint VISTA exhibits high expression levels in human gliomas and associates with a poor prognosis.
Amina Ghouzlani, Abdelhakim Lakhdar, +2 authors, Abdallah Badou.
Sci Rep, 2021 Nov 04; 11(1). PMID: 34728682    Free PMC article.
Current Progress and Future Perspectives of Immune Checkpoint in Cancer and Infectious Diseases.
Xin Cai, Huajie Zhan, +4 authors, Yuan Zhuang.
Front Genet, 2021 Dec 18; 12. PMID: 34917131    Free PMC article.
Kidney VISTA prevents IFN-γ/IL-9 axis-mediated tubulointerstitial fibrosis after acute glomerular injury.
Min-Gang Kim, Donghwan Yun, +11 authors, Seung Seok Han.
J Clin Invest, 2021 Nov 10; 132(1). PMID: 34752423    Free PMC article.
Ablation of T cell-associated PD-1H enhances functionality and promotes adoptive immunotherapy.
Li Hu, Ling Chen, +7 authors, Lieping Chen.
JCI Insight, 2021 Dec 15; 7(2). PMID: 34905507    Free PMC article.
Negative Immune Checkpoint Protein, VISTA, Regulates the CD4+ Treg Population During Sepsis Progression to Promote Acute Sepsis Recovery and Survival.
Chyna C Gray, Bethany Biron-Girard, +5 authors, Alfred Ayala.
Front Immunol, 2022 Apr 12; 13. PMID: 35401514    Free PMC article.
The Role of Immune Checkpoint Molecules on Macrophages in Cancer, Infection, and Autoimmune Pathologies.
Victoria C Brom, Christof Burger, Dieter C Wirtz, Frank A Schildberg.
Front Immunol, 2022 Apr 15; 13. PMID: 35418973    Free PMC article.
Exploring the Pro-Phagocytic and Anti-Inflammatory Functions of PACAP and VIP in Microglia: Implications for Multiple Sclerosis.
Margo I Jansen, Sarah Thomas Broome, Alessandro Castorina.
Int J Mol Sci, 2022 May 15; 23(9). PMID: 35563181    Free PMC article.